Increased expression of P-gp causes drug resistance, as evidenced by studies showing high P-gp expression in CRC cells resistant to chemotherapy drugs such as 5-FU, doxorubicin, and oxaliplatin [163–165]. The gene discussed is PGP; the disease is colorectal carcinoma.